Drug Shortage Report for MYLAN-MIRTAZAPINE
Report ID | 186407 |
Drug Identification Number | 02256126 |
Brand name | MYLAN-MIRTAZAPINE |
Common or Proper name | MIRTAZAPINE |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | MIRTAZAPINE |
Strength(s) | 45MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100BT |
ATC code | N06AX |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2023-05-25 |
Actual start date | 2023-05-25 |
Estimated end date | 2023-07-11 |
Actual end date | 2023-07-10 |
Shortage status | Resolved |
Updated date | 2023-10-03 |
Company comments | Quality Hold |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v24 | 2023-10-03 | French | Compare |
v23 | 2023-10-03 | English | Compare |
v22 | 2023-07-14 | French | Compare |
v21 | 2023-07-14 | English | Compare |
v20 | 2023-06-13 | French | Compare |
v19 | 2023-06-13 | English | Compare |
v18 | 2023-05-31 | French | Compare |
v17 | 2023-05-31 | English | Compare |
v16 | 2023-05-25 | English | Compare |
v15 | 2023-05-23 | French | Compare |
v14 | 2023-05-23 | English | Compare |
v13 | 2023-05-18 | English | Compare |
v12 | 2023-05-16 | French | Compare |
v11 | 2023-05-16 | English | Compare |
v10 | 2023-05-16 | French | Compare |
v9 | 2023-05-16 | English | Compare |
v8 | 2023-05-11 | English | Compare |
v7 | 2023-05-08 | French | Compare |
v6 | 2023-05-08 | English | Compare |
v5 | 2023-05-01 | French | Compare |